Curcumin-carrying nanoparticles prevent ischemia-reperfusion injury in human renal cells

Oncotarget. 2016 Dec 27;7(52):87390-87401. doi: 10.18632/oncotarget.13626.

Abstract

Renal ischemia-reperfusion injury (IRI) is a major complication in clinical practice. However, despite its frequency, effective preventive/treatment strategies for this condition are scarce. Curcumin possesses antioxidant properties and is a promising potential protective agent against renal IRI, but its poor water solubility restricts its application. In this study, we constructed curcumin-carrying distearoylphosphatidylethanolamine-polyethylene glycol nanoparticles (Cur-NPs), and their effect on HK-2 cells exposed to IRI was examined in vitro. Curcumin encapsulated in NPs demonstrated improved water solubility and slowed release. Compared with the IRI and Curcumin groups, Cur-NP groups displayed significantly improved cell viability, downregulated protein expression levels of caspase-3 and Bax, upregulated expression of Bcl-2 protein, increased antioxidant superoxide dismutase level, and reduced apoptotic rate, reactive oxygen species level, and malondialdehyde content. Results clearly showed that Cur-NPs demonstrated good water solubility and slow release, as well as exerted protective effects against oxidative stress in cultured HK-2 cells exposed to IRI.

Keywords: Curcumin; ischemia-reperfusion injury; nanoparticles.

MeSH terms

  • Apoptosis / drug effects
  • Caspase 3 / metabolism
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Curcumin / chemistry
  • Curcumin / pharmacology*
  • Humans
  • Kidney / blood supply*
  • Nanoparticles*
  • Proto-Oncogene Proteins c-bcl-2 / analysis
  • Reactive Oxygen Species / metabolism
  • Reperfusion Injury / prevention & control*
  • Solubility

Substances

  • Proto-Oncogene Proteins c-bcl-2
  • Reactive Oxygen Species
  • CASP3 protein, human
  • Caspase 3
  • Curcumin